- Proteomics International meeting with US tier 1 national diagnostic groups to expand global roll-out of PromarkerD including EU and Mexico

- PromarkerD world's leading diagnostic test for diabetic kidney disease says Frost & Sullivan industry report 'Biomarkers Enabling Diabetes and Obesity Management'

PromarkerD, the world leading predictive diagnostic test for DKD, launched in Dominican Republic this month, with new markets planned in mainland USA, Mexico, Japan, Australia, China and Europe

- PromarkerD predicted 86% of disease-free patients who went on to develop chronic kidney disease within four years
- Largest prospective clinical study on diabetic kidney disease in the community, evaluating 792 patients over 4yr period
- Presented at American Diabetes Association's 77th Annual Scientific Sessions, 9-13th June in San Diego

Proteomics International, leader in predictive diagnostics for DKD, is advancing deals with commercialisation partners in Singapore and China this week